A B S T R A C T The renal extraction and excretion of bovine proinsulin, insulin, and C-peptide and the contribution of the kidney to their total metabolic clearance rate (MCR) were studied in the rat. Metabolic clearance rates were measured by the constant infusion technique and plasma and urine concentrations of each polypeptide were determined by radioimmunoassay.
INTRODUCTION
Differential secretion rates of insulin, proinsulin, and C-peptide by pancreatic beta cells have generally been considered to be the major determinant of their plasma concentrations (1) (2) (3) . However, in vivo and in vitro studies have indicated that the peripheral distribution, metabolism, and degradation of insulin and proinsulin differ, suggesting that these factors may play an important role in determining their blood levels. Thus, the half disappearance time of proinsulin in dogs (4), swine (5), rats (6) , and baboons (5) is two-to threefold longer than that of insulin. Experiments with the isolated perfused liver (7, 8) have shown a high clearance of insulin compared with the removal of proinsulin. Tissue homogenates (9) and specific proteases purified from liver, kidney, and skeletal muscle (10) (11) (12) (13) degrade insulin at a significantly faster rate than proinsulin, and isolated liver plasma membranes (14) have a greater affinity for insulin compared with proinsulin. Nevertheless, the metabolic clearance rates of these polypeptides have not been measured under comparable experimental conditions, and there is as yet no information concerning the peripheral metabolism of C-peptide.
In the present study we measured the metabolic clearance rate (MCR) ' of the unlabeled bovine proinsulin, insulin, and C-peptide in anesthetized rats by the constant infusion technique. As the kidney is probably the 'Abbreviations used in this paper: APAH, arterial concentration of PAH; C,,a clearance of inulin; EPAH, PAH exThe Journal of Clinical Investigation Volume 52 May 1973 May -1113 May -1121 1113 most important organ involved in the removal of these polypeptides from the systemic circulation, the renal extraction and excretion of proinsulin, insulin, and C-peptide were studied under identical experimental conditions, and the contribution of the renal clearance of each polypeptide to its total metabolic clearance rate was assessed.
METHODS
Infusion studies. Male Sprague-Dawley rats (300-420 g) had free access to water and a pellet rat diet until surgery. Animals were anesthetized with Inactin (Promonta, Hamburg, West Germany) 120 mg/kg intraperitoneally, a tracheostomy was performed, and the bladder, a jugular vein, and one carotid artery were cannulated with polyethylene PE50 catheters. After exposure of the left renal vein, the adrenal and spermatic veins were ligated and the rats were placed on a heated animal board. Rectal temperature, monitored by a thermistor probe (Yellow Springs Instrument Co., Inc., Yellow Springs, Ohio), was maintained between 370C and 380C. During surgery, isotonic saline equal to 0.5-1% of the body weight was infused intravenously to replace estimated fluid losses.
Following priming doses of 20 mg inulin and 3 mg paminohippurate (PAH), a sustaining solution calculated to maintain plasma levels at approximately 50 and 3 mg/100 ml, respectively, was delivered with constant infusion pumps (Harvard Model 975; Harvard Apparatus Co., Inc., Millis, Mass.) at the rate of 40 btl/min. Bovine proinsulin, insulin, and C-peptide were infused at different rates (15-100 ng/ min) to obtain a wide range of steady-state plasma concentrations, as indicated in the Results section. Each polypeptide was infused separately, together with the infusion of inulin and PAH. After an equilibration period of 60 min, urine was collected under mineral oil and volumes measured with glass micropipettes. In each experiment three to four consecutive collection periods of 30 min each were obtained, and arterial blood was drawn in heparinized capillary tubes before and after each collection period. After completion of urine collections, two arterial samples were drawn simultaneously with two renal venous blood samples at 15- pedicles were tied and five additional blood samples were drawn at 15-min intervals. Materials. Bovine proinsulin and insulin were purified from first crystals of insulin (kindly supplied by the Novo Company, Copenhagen, Denmark) (15) . Immunoassay of fractions after gel filtration showed less than 0.3% contamination of proinsulin with material eluting in the insulin region of the column, while the insulin was essentially free of early eluting components. C-peptide was isolated from bovine pancreas and purified by procedures which have been described previously (16) . Solutions for the infusion experiments and immunoassay standards were made from the same batches of material. The infusate was prepared in isotonic saline from a stock solution of polypeptide (400 pgg/ml) dissolved in tris-HCL buffer (pH 7.4) containing 1% bovine serum albumin to prevent loss by adsorption into glassware and polyethylene tubing. Polypeptide concentrations in the infusate were verified by measuring a portion together with the blood and urine samples from the same experiments.
Chemical and immunological methods. Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were calculated from the clearance of inulin and PAH, respectively. Plasma and urine concentrations of inulin and PAH were determined in duplicate samples by semimicro modifications of the anthrone (17) and diazotization (18) methods. Glucose was measured by the glucose oxidase method (19) . The polypeptides were measured by a modification of the double antibody immunoassay of Morgan and Lazarow (20) . Bovine [1'5I] proinsulin and a purified bovine proinsulin antiserum which did not cross react with rat insulin nor rat C-peptide (and presumably rat proinsulin) at concentrations up to 20 ng/ml were used to assay bovine proinsulin. Bovine C-peptide was measured using a bovine proinsulin antiserum and synthetic [1"I]tyrosyllated bovine C-peptide (kindly supplied by Dr. N. Yaniahara). Rat insulin and C-peptide (20 ng/ml) did not cross-react in this assay system. The rat C-peptide (kindly supplied by Dr. H. Tager) also did not compete with ['5I]insulin in the insulin assay. Because bovine insulin, proinsulin, and C-peptide were infused in separate experiments, the individual assay characteristics described above ensured the specific measurement of each infused bovine polypeptide.
Gel filtration. Selected plasma samples (0.1-0.5 ml) were gel filtered (1, 2) on 1 X 50 cm columns of Biogel P-30 (Bio-Rad Laboratories, Richmond, Calif.) equilibrated in 3 M acetic acid (C-peptide experiments) and borate albumin buffer, pH 8 [12. .I]tyrosyllated C-peptide. Portions of the column fractions from the experiments in which proinsulin was infused, were measured in the bovine proinsulin, C-peptide, and insulin assays. As bovine proinsulin and C-peptide reacted on an equimolar basis in the bovine proinsulin assay, degradation of proinsulin to C-peptide would have been readily detected by this method, as well as in the C-peptide assay. Preliminary experiments (carried out in conjunction with Dr. Yaniahara) have demonstrated that certain synthetic fragments of bovine C-peptide do cross-react in the bovine C-peptide immunoassay system. If the infused bovine C-peptide, or proinsulin were degraded to these smaller fragments in the circulation, material reacting in the Cpeptide assay should have been detected in column fractions eluting later than the intact C-peptide.
Calculations. 
RESULTS
Prelinaiiiiry experiments. A number of preliminary experiments were performed to validate the methods used in this study. First, because rat insulin crossreacts in the bovine insulin assay, the minimal concentration of the hormone capable of lowering plasma glucose to levels which do not stimulate endogenous insulin release was determined. The initial plasma glucose in seven rats was 119±4 mg/100 ml. After administration of a priming dose of 500 ng insulin, a sustaining infusion of 30 ng/min-the lowest infusate concentration used in subsequent experiments-was started. After the 60 min equilibration period, plasma glucose had fallen to 53±4 mg/100 ml and remained low for the subsequent 2 h when plasma samples for estimation of the MICR were obtained (53±2 mg/100 ml at 120 min and 37±3 mg/100 ml at 180 min). As the circulating insulin of 24-h fasted rats with a mean plasma glucose of 65 mg/100 ml was only 0.2 ng/ml, we concluded that the interference from endogenous insulin at glucose levels of 53 mg/100 ml or less would be negligible. Although it is appreciated that the insulin experiments were performed in mildly hypoglycemic animals, the need to suppress endogenous insulin release necessitated this approach.
At the termination of each experiment, rats were exsanguinated to obtain sufficient plasma for dilution 2 Throughout this study renal clearance denotes milliliters of plasma cleared of each polypeptide by the kidney in 1 min and should not be confused with the urinary clearance which represents only the negligible fraction of the former that can be accounted for by urinary excretion. studies and, in selected samples, for column fractionation. Plasma portions varying from 25 to 250 Al gave similar values when calculated from the appropriate bovine peptide standard and corrected for the quantity assayed. Recovery of bovine insulin, proinsulin, and C-peptide (1.0-4.0 ng) added to rat urine and plasma ranged between 94 and 102%. Plasma specimens showed single immunologically identifiable peaks in their expected position after gel filtration. Specifically, we were unable to show small molecular weight fragments of bovine C-peptide eluting from the column in a position later than the intact C-peptide. In order to detect possible conversion of proinsulin to insulin and C-peptide (22) , column fractions from the proinsulin experiments were also assayed in the insulin and C-peptide systems. No conversion to these polypeptides could be demonstrated. The total quantity of polypeptide recovered after gel filtration (82-98%) corresponded closely to the direct assay result.
Metabolic clearance rates. The mean metabolic clearance rate of insulin (16.4±0.4 ml/min) was significantly (P < 0.001) greater than that of either proinsulin (6.7 ±0.3 ml/min) or C-peptide (4.6+0.2 ml/min) ( Table  I) . The difference between the MCR of proinsulin and C-peptide was also significant (P <0.001). The metabolic clearance rates were independent of plasma levels ( Fig. 1 ) over a range of steady-state plasma concentrations varying from less than 2 to more than 15 ng/ml.
Renal extraction and excretion. In contrast to the total metabolic clearance rate, the renal disposition of proinsulin, insulin, and C-peptide was similar, being Metabolism of Proinsulin, Insulin, and C-Peptide characterized by high extraction and very low urinary clearance rates (Table I ). Both the renal extraction and the urinary clearance were highest for C-peptide and lowest for proinsulin, with insulin occupying an intermediate position (Fig. 2) . The renal arteriovenous difference of each polypeptide ranged between 36 and 44%. However, their fractional urinary excretion (peptide clearance/inulin clearance X 100) averages less than 0.6%, indicating that more than 99% of the proinsulin, insulin, and C-peptide filtered was sequestered in the renal tubular cells.
The renal extraction of proinsulin, insulin, and Cpeptide was linearly related to their concentration in arterial blood between 2 and 25 ng/ml (Fig. 3) . Thus, there was no evidence of saturation of the renal extraction process of any of the three polypeptides even at concentrations well in excess of those usually found in the postabsorptive state or after pancreatic stimulation by pharmacological agents.
In order to evaluate the contribution of the renal clearance of proinsulin, insulin, and C-peptide to their total MCR, we analyzed separately the results from and renal clearance those rats in which measurements of glomerular filtration rate, renal plasma flow, and renal extraction and MCR of the respective polypeptide were made in the same clearance period (Table II) . The renal clearances of proinsulin, insulin, and C-peptide, estimated from the renal plasma flow and renal arteriovenous difference, ranged between 3 and 5 ml/min and were not significantly different from each other. Nevertheless, their contribution to the respective total metabolic clearance rate was markedly different due to the large differences between the MCR of insulin on the one hand, and the MCR of proinsulin and C-peptide on the other. Thus, while the renal clearance of proinsulin and C-peptide accounted for 55% and 69% of their respective MCR, the renal contribution to the peripheral metabolism of insulin was much smaller, averaging only 33% of its total metabolic clearance rate (Fig. 4 ).
In the above experiments the mean renal clearance of proinsulin and insulin was similar to the glomerular filtration rate as measured by the clearance of inulin.
The mean renal clearance of C-peptide, however, exceeded that of inulin (P <0.001) suggesting that this Ci., clearance of inulin; UV, urine flow. polypeptide was extracted in part from postglomerular ceeded the clearance of inulin in four of eight rats. By plasma. Results from individual experiments revealed contrast, the renal clearance of C-peptide was higher that proinsulin clearance was higher than that of inulin than the clearance of inulin in each of the eight animals in four of nine animals and the insulin clearance ex-tested. To clarify the mechanism whereby proinsulin, insulin, and C-peptide are removed by the kidneys from the circulation, the renal extraction of each polypeptide was compared to the extraction of inulin in kidneys in which the ureter was tied off (Table III) . Inulin extraction stopped in approximately one-half of the animals, and ranged between 1.1 and 13.3% in the remainder. The extraction of each polypeptide was invariably greater than the corresponding extraction of inulin, and the differences between mean values were highly significant.
The role of the kidney in the metabolism of circulating proinsulin, insulin, and C-peptide was also evalu- (Fig. 6 ). DISCUSSION The metabolism, distribution, and half disappearance time of insulin has been studied in man and animals following the rapid injection of both the labeled and unlabeled hormone (23) (24) (25) (26) . The problems inherent in this approach have been pointed out by Corvilain et al. (27) and the potential advantage of the constant infusion technique for the measurement of the metabolic clearance rate of insulin has been discussed. Because of the possibility that even lightly iodinated insulin may not be metabolized identically to the native hormone (28) , unlabeled polypeptides were infused in the present experiments.
The MCR of insulin varies in different species even when corrected for their body size. Thus Ooms et al. reported a value of 400 ml/min in dogs weighing 19-35 kg (28), while Swenson and his colleagues (29) determined that the irreversible loss rate of insulin from the plasma compartment of dogs weighing 14-24 kg was 1798 AU/min at a mean plasma level of 19 ,uU/ml. Tompkins, Srivastava, Sonksen, and Nabarro (30) found that the MCR of insulin ranged from 9.7 to 17.8 ml/kg per min in man, but a much lower value of 5.6 ml/kg per min in fasting control subjects was obtained by Corvilain et al. (27) . As expected, the metabolic clearance rate of insulin measured in rats in the present experiments (45-50 ml/kg per min) was more rapid when compared with the values in larger mammals. Moreover, in contrast to the results obtained with insulin in man (30) and dog (28) , there was no decline in the MCR as the blood polypeptide levels increased within the physiological range.
Although it would have been preferable to use the homologous species of polypeptide, this was not possible due to the limited availability of rat C-peptide and proinsulin. Nevertheless, the difference between the metabolic clearance rates of bovine proinsulin and insulin observed in rats is comparable to data derived 1lls (7) demonstrated that the porcine peptide was not taken up by the isolated perfused rat liver. The present experiments in anesthetized rats indicate that the metabolic clearance rate of C-peptide is the slowest of the three polypeptides studied, and, like the MICR of proinsulin and insulin, was independent of plasma concentrations.
Although there is no obvious reason to believe that anesthesia would have modified these results, its specific effects on the parameters studied were not investigated. The renal handling of proinsulin, insulin, and C-peptide was characterized by high extraction rates and very low urinary clearances, indicating that almost all the polypeptide removed from the circulation was sequestered or metabolized in the kidney. Kidney homogenates are known to destroy insulin in vitro (11, 32) , and autoradiographic studies in the rat show that labeled insulin accumulates in the cells of the proximal convoluted tubules (33, 34) , where it presumably undergoes degradation. It is of interest that other small molecular weight polypeptides are handled by the kidney in similar fashion. Thus, high renal arteriovenous concentration differences and low urinary excretion rates of parathyroid hormone (35) , gastrin (36), P2-microglobulin (37) , and angiotensin (38) have been reported in several species.
The mean renal arteriovenous difference of insulin was 40%, which is in good agreement with values of 29% (39) and 39% (40) reported in man and of 41% in the dog (41) . The renal extraction of insulin in the rat was proportional to its arterial concentration in the range between 1 and 15 ng/ml, the latter value exceeding physiological levels in the fed state. A similar linear relationship between the extraction of insulin and its arterial level was also found in dogs (41) and man (39, 40) . The renal extraction of proinsulin and C-peptide in the present experiments was also linearly related to their arterial plasma concentrations up to levels of 25 iig/ml. It appears therefore that the renal normial subjects (39) and dogs (42) has been adduced as evidence that in these species, insulin is cleared by direct tubular uptake from the postglomerular capillaries in addition to glomerular filtration. The extraction rates observed in the present study would suggest that in the rat, insulin, as well as proinsulin and C-peptide, are also cleared by these two processes. This conclusion cannot be reached, however, on the basis of magnitude of renal extraction alone, since the filtration fraction in the rat is higher than in dog and man, and frequently exceeds 0.40. We therefore evaluated the mechanism of polypeptide extraction by a more direct approach in which the arteriovenous concentration difference of each polypeptide and of inulin were measured simultaneously in kidneys in which the glomerular filtration was stopped or markedly reduced by ureteral obstruction (Table  III) . Substantial renal extraction of proinsulin, insulin, and C-peptide continued even when the extraction of inulin was abolished and thus glomerular filtration had stopped. This observation provides convincing evidence for the occurrence of direct tubular uptake of all three polypeptides in the rat. The fractional urinary clearance of insulin averaged 0.2% which was considerably smaller than that found in the dog (about 10%) (41) , but similar to the values reported in normal man (39, 40, 43) . The urinary clearance of insulin was significantly less than that of C-peptide, but was greater than that of proinsulin (Fig. 2) , suggesting an inverse relationship with the molecular weight of these polypeptides. The meaning of this observation is not clear since substances with molecular weight in the range of 3000-9000' should be readily filterable through the glomerular barrier (45) .
The renal clearance of insulin represented one-third of its total metabolic clearance rate whereas the renal contribution to the peripheral metabolism of proinsulin and C-peptide was considerably higher, averaging approximately two-thirds of their respective MCR (Fig.  4) . The results were comparable, whether based on the simultaneous determination of renal clearance and MCR or on the measurement of metabolic clearance rates before and after exclusion of the kidneys from the circulation. Since the renal clearance of all three polypeptides was similar, its variable contribution to their total MCR is explained by the difference between the MCR of insulin on the one hand and that of proinsulin and C-peptide on the other. As discussed above, this difference is probably due to the fact that insulin, but not the other polypeptides, is metabolized to a significant extent by the liver. The results also suggest that sThe approximate molecular weight of C-peptide, insulin, and proinsulin is 3000, 6000, and 9000, respectively. They are believed to be present in the circulation in their monomeric form, and not hound to other plasma proteins (44) . circulating concentrations of these polypeptides might be elevated in patients with renal failure, and our preliminary experiments are consistent with this possibility.
